rs6457937

Variant summary

Our verdict is Uncertain significance.
+2 Uncertain · Warm
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 2 classification points (ACGS-UK Somatic Oncogenicity v2025). O3_Moderate

The NM_000389.5(CDKN1A):c.*774T>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The gene CDKN1A is a tumor suppressor gene (CancerMine: 79 TSG, 80 oncogene, 4 driver citations). The gene CDKN1A is a known oncogene (CancerMine: 79 TSG, 80 oncogene, 4 driver citations). The variant allele was found at a cumulative frequency of 0.00000657 (AC=1) in the gnomAD database across 152,126 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.0000147. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 30)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

CDKN1A
NM_000389.5 3_prime_UTR

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.622

Publications

10 publications found
Variant links:
Genes affected
CDKN1A (HGNC:1784): (cyclin dependent kinase inhibitor 1A) This gene encodes a potent cyclin-dependent kinase inhibitor. The encoded protein binds to and inhibits the activity of cyclin-cyclin-dependent kinase2 or -cyclin-dependent kinase4 complexes, and thus functions as a regulator of cell cycle progression at G1. The expression of this gene is tightly controlled by the tumor suppressor protein p53, through which this protein mediates the p53-dependent cell cycle G1 phase arrest in response to a variety of stress stimuli. This protein can interact with proliferating cell nuclear antigen, a DNA polymerase accessory factor, and plays a regulatory role in S phase DNA replication and DNA damage repair. This protein was reported to be specifically cleaved by CASP3-like caspases, which thus leads to a dramatic activation of cyclin-dependent kinase2, and may be instrumental in the execution of apoptosis following caspase activation. Mice that lack this gene have the ability to regenerate damaged or missing tissue. Multiple alternatively spliced variants have been found for this gene. [provided by RefSeq, Sep 2015]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000389.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 2 points.

O3Absent or very rare in population
Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = 0.000015, AC = 1 — absent/extremely rare (O3 moderate [+2])

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000389.5. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

CDKN1A NM_000389.5
MANE Select
HGVSc / HGVSpc.*774T>A
Exon rankExon 3 of 3
3_prime_UTR
Prot: NP_000380.1UniProt: P38936
CDKN1A NM_001291549.3
HGVSc / HGVSpc.*774T>A
Exon rankExon 4 of 4
3_prime_UTR
Prot: NP_001278478.1
CDKN1A NM_001374509.1
HGVSc / HGVSpc.*774T>A
Exon rankExon 4 of 4
3_prime_UTR
Prot: NP_001361438.1

Ensembl Transcripts

CDKN1A ENST00000244741.10
TSL:1MANE Select
HGVSc / HGVSpc.*774T>A
Exon rankExon 3 of 3
3_prime_UTR
Prot: ENSP00000244741.6UniProt: P38936
CDKN1A ENST00000405375.5
TSL:1
HGVSc / HGVSpc.*774T>A
Exon rankExon 3 of 3
3_prime_UTR
Prot: ENSP00000384849.1UniProt: P38936
CDKN1A ENST00000373711.4
TSL:5
HGVSc / HGVSpc.*774T>A
Exon rankExon 4 of 4
3_prime_UTR
Prot: ENSP00000362815.1UniProt: P38936

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 5 sources
GnomAD3 genomes
AF: 0.00000657
AC:1
Hom:0
AN:152126
Cov:30
GnomAD4 exome Warning
AF: 0.00
AC:0
Hom:0
AN:81712
Cov:0
GnomAD4 genome
AF: 0.00000657
AC:1
Hom:0
AN:152126
Cov:30
TOPMed (Bravo)
AF: 0.160
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.00
AC:0
Hom:6925
AN:14476
Showing 5 sources

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Benign1.6
BayesDel_noAF
Benign-0.85
CADD
Benign2.5
DANN
Benign0.55
GPN-Star LLR
N/A2.3
GPN-Star score
N/A-2.3
PhyloP100
Benign-0.62
RBP_binding_hub_radar
N/A0.0
RBP_regulation_power_radar
N/A1.1
Showing 9 of 9 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.